Lauren E. Haydu, PhD MPH

Citado por

	Todos	Desde 2019
Citações	80257	44131
Índice h	67	56
Índice i10	147	137

10000

5000

2500

7500

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320241049 1691 1766 1656 1792 1774 1651 1665 1539 1559 1608 1869 1987 2126 2326 2645 2904 3675 5624 7826 9119 9372 8791 3366

Acesso público

Ver todos

88 artigos

4 artigos*

disponível

não disponível

Com base nas autorizações de financiamento

Coautores

John F ThompsonMelanoma Institute AustraliaE-mail confirmado em melanoma.org.au
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalE-mail confirmado em sswahs.nsw.gov.au
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalE-mail confirmado em sydney.edu.au
Alexander M MenziesMelanoma Institute Australia, The University of Sydney, Royal North Shore HospitalE-mail confirmado em sydney.edu.au
Richard KeffordMacquarie UniversityE-mail confirmado em mq.edu.au
Robyn SawMelanoma Institute AustraliaE-mail confirmado em melanoma.org.au
A SpillaneUniversity of SydneyE-mail confirmado em melanoma.org.au
Jonathan StretchMelanoma Institute AustraliaE-mail confirmado em melanoma.org.au
Jeff GershenwaldThe University of Texas MD Anderson Cancer CenterE-mail confirmado em mdanderson.org
Graham MannCollege of Health and Medicine, Australian National UniversityE-mail confirmado em anu.edu.au
Gerald FogartyICON Cancer Centre, Revesby, Sydney NSW.E-mail confirmado em Icon.Team
James S WilmottMelanoma Institute Australia, The University of SydneyE-mail confirmado em sydney.edu.au
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer CtrE-mail confirmado em mdanderson.org
Carlino Matteo SMelanoma Institute Australia; Westmead HospitalE-mail confirmado em sydney.edu.au
Jennifer Leigh McQuadeInstructor of Melanoma Medical Oncology, UT MD Anderson Cancer CenterE-mail confirmado em mdanderson.org
Rajmohan MuraliMemorial Sloan Kettering Cancer CenterE-mail confirmado em mskcc.org
Serigne LoMelanoma Institute Australia, The University of SydneyE-mail confirmado em melanoma.org.au
Peter HerseyE-mail confirmado em sydney.edu.au
Helen RizosMacquarie UniversityE-mail confirmado em mq.edu.au
Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLE-mail confirmado em moffitt.org

Seguir

Lauren E. Haydu, PhD MPH

Mayo Clinic

E-mail confirmado em mayo.edu

Biostatistician


Título Ordenar por citações Ordenar por ano Ordenar por título	Citado por Citado por	Ano
Initial sequencing and analysis of the human genome US DOE Joint Genome Institute: Hawkins Trevor 4 Branscomb Elbert 4 Predki ... nature 409 (6822), 860-921, 2001	30569	2001
Finishing the euchromatic sequence of the human genome International Human Genome Sequencing Consortium Nature 431 (7011), 931-945, 2004	5193	2004
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4413	2018
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018	3869	2018
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015	2676	2015
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2589	2018
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2453	2018
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017	2226*	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2161	2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2024	2018
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020	1690	2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1586	2018
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ... Journal of Clinical Oncology 29 (10), 1239-1246, 2011	1270	2011
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016	929	2016
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	827	2018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018	712	2018
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018	712	2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018	707	2018
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma JS Wilmott, GV Long, JR Howle, LE Haydu, RN Sharma, JF Thompson, ... Clinical cancer research 18 (5), 1386-1394, 2012	668	2012
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas T Palomero, L Couronné, H Khiabanian, MY Kim, A Ambesi-Impiombato, ... Nature genetics 46 (2), 166-170, 2014	659	2014

O sistema não pode executar a operação agora. Tente novamente mais tarde.

Artigos 1–20

Citações por ano

Citações duplicadas

Citações mescladas

Adicionar coautoresCoautores

Seguir

Citado por

Coautores